EP3437645

INTERCEPT PHARMACEUTICALS
Application Number
EP17775388A
Filing Date
Mar 30, 2017
Status
Revoked
Feb 10, 2023
Grant Date
Sep 22, 2021
External Links
Slate, Register, Google Patents
Similar Patents facing opposition

Bibliography

The patent EP3437645B1 was granted to Intercept Pharmaceuticals on Sep 22, 2021 following the initial filing on Mar 30, 2017 under the application number EP17775388A . The current legal status of the patent is Revoked.

AI Generated Summary New

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

SANDOZJun 21, 2022ADMISSIBLE

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history, including filings, correspondence, and decisions made by patent offices. These documents are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination. It also includes the oppositions documents filed against the patent.

  • Date

    Description

  • Get instant alerts for new documents